Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Jeffrey W. Baumgartner, Executive Vice President of Research & Development at Cirrus Logic, Inc. (NASDAQ: CRUS), completed a stock sale on June 22, 2026, divesting 1,170 shares of the company's common stock. The transaction, valued at $196,829, was executed at a price of $168.23 per share and was conducted under the guidelines of a Rule 10b5-1 trad…
Datadog, Inc. (NASDAQ:DDOG) Chief Technology Officer and director Alexis Le-Quoc sold 43,224 shares of the company's Class A Common Stock on June 22, 2026. The transaction, valued at $9,551,316, was executed through a pre-arranged 10b5-1 trading plan established on June 13, 2025. The sale follows a 69% surge in Datadog's stock price over the past y…
Verastem, Inc. (NASDAQ: VSTM) President and CEO Dan Paterson completed a transaction involving the sale of 20,871 common shares on June 22, 2026. Executed at $4.18 per share, the transaction yielded $87,240. This sale was necessitated by statutory withholding requirements tied to the vesting of restricted stock units rather than a discretionary dec…
Verastem, Inc. (NASDAQ:VSTM) reported a recent stock sale by its Chief Financial Officer, Daniel Calkins, alongside positive updates from its clinical development pipeline. While Calkins disposed of 4,089 shares to cover withholding obligations tied to restricted stock unit vesting, the company continues to advance its oncology programs. The stock …
Cheryl M. Kirkbride, a director at CSB Bancorp, Inc. (NASDAQ: CSBB), has purchased additional shares of the company's stock. This transaction occurs as the stock trades near its 52-week high and the company prepares for its annual shareholder meeting, where key governance decisions were made. The acquisition adds to her existing direct and indirect…
Freedom Holding Corp. (NASDAQ: FRHC) Chief Technology Officer Renat Tukanov executed a sale of 1,800 shares of common stock on June 22, 2026, generating proceeds of $253,476. The transaction, priced at $140.82 per share, was completed at a premium to the stock's current trading level of $135.45. Following the divestment, Tukanov retains direct owne…
William J.G. Griffith, a director and ten percent owner of ServiceTitan, Inc. (NASDAQ:TTAN), has completed the sale of Class A Common Stock valued at $600,119.1 over June 22 and June 23, 2026. The transactions involved the disposal of 94,615 shares at prices ranging from $63.01 to $64.1806 per share. The insider sales come as ServiceTitan stock cur…
Ned S. Holmes, a director at Prosperity Bancshares Inc. (NASDAQ:PB), executed a series of equity transactions on June 24, 2026, resulting in the sale of 1,100 shares valued at $79,997. The transactions, conducted through direct sales, a profit-sharing plan, and a trust, reflect a strategic divestment by the insider. Concurrently, market analysts ha…
Centerspace director Rodney Jones-Tyson has executed a significant share purchase, acquiring 1,700 common shares of beneficial interest on June 22, 2026. The transaction, valued at $93,942, brings his direct ownership to 7,877 shares. This insider activity unfolds against a backdrop of recent financial reporting that missed analyst expectations, co…
Devon WB Holdco L.L.C., an indirect subsidiary of Devon Energy Corporation, executed a significant divestiture of WaterBridge Infrastructure LLC shares on June 22, 2026. The transaction involved the sale of 1,755,174 Class A shares at $30.05 per share, totaling $52,742,978. This move followed a complex internal restructuring involving the redemptio…
Liquidia Corp (NASDAQ:LQDA) director Stephen Bloch executed a substantial divestiture of company equity on June 22, 2026, realizing approximately $7.57 million from the sale of common stock. The transaction involved two distinct blocks of shares traded between $75.00 and $76.42 per share, bringing the total volume to 100,000 shares. This sale occur…
Martine A. Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corp. (NASDAQ:UTHR), sold 9,500 shares of the company’s common stock for a total of $5,167,570 on June 23, 2026. The sales were executed at prices ranging from $539.62 to $546.55 per share. These transactions were conducted pursuant to a pre-arranged 10b5-1 trading…
Mink Brook Asset Management LLC has increased its position in DLH Holdings Corp. (NASDAQ:DLHC) through two separate funds, purchasing shares at $5.50 each across June 23 and June 24, 2026. The activity occurs as DLHC trades near its 52-week low of $5.41, despite analyst consensus maintaining a $10 price target. The insider buying follows a fiscal 2…
Ford Motor Co. director John L. Thornton executed a $148,880 purchase of 10,600 shares on June 23, 2026, bringing his direct holdings to 486,685 shares. The transaction occurs against a backdrop of corporate recalls, debt issuance, labor negotiations, and supply chain recoveries, while valuation metrics present a mixed outlook for investors.
Omada Health, Inc. (OMDA) Chief Accounting Officer Craig Gracey has executed a stock sale totaling $37,494, according to a Form 4 filing with the Securities and Exchange Commission. The transaction, which involved the disposal of 2,083 shares at $18.00 per share, was carried out under a 10b5-1 trading plan established earlier this year. This move o…
Twist Bioscience Corp (TWST) Chief Legal Officer Dennis Cho sold 346 shares on June 22, 2026, in a non-discretionary transaction to cover tax withholding obligations. The sale occurred as the company's stock trades near its 52-week high, with multiple analyst firms recently upgrading their outlooks based on the company's expanding role in AI-driven…
Emily M. Leproust, Chief Executive Officer of Twist Bioscience Corp (NASDAQ:TWST), executed a sale of 1,688 shares of the company's common stock on June 22, 2026. The transaction occurred at a price of $87.32 per share, resulting in total proceeds of approximately $147,400. This activity was classified as a "sell to cover" event, indicating that th…
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. DuChene sold 10,000 shares of common stock on June 22, 2026, totaling approximately $292,939. The sales were executed under a Rule 10b5-1 trading plan adopted in December 2025, with prices ranging from $28.61 to $30.32 per share. Following the transaction, DuChene retains d…
Raymond C. Stachowiak, Executive Chairman of American Shared Hospital Services (NASDAQ: AMS), has significantly expanded his indirect ownership in the company through a substantial private stock acquisition. The transaction, reported via a Form 4 filing with the U.S. Securities and Exchange Commission, underscores a notable commitment by the execut…
Rigel Pharmaceuticals (NASDAQ:RIGL) Director Ali-Jackson Kamil sold 2,500 shares of the company's common stock on June 22, 2026, generating proceeds of $87,500. The transaction was executed at a price of $35.0 per share and was facilitated through a Rule 10b5-1 trading plan established on November 7, 2025. The sale was specifically designated to co…
Lynn Radakovich, a director at Dell Technologies Inc. (NASDAQ:DELL), executed a series of transactions totaling $5,061,262 on June 22, 2026, involving the sale of Dell shares. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted in March 2026. This activity occurs against a backdrop of Dell's stock performance, whic…
Liquidity Services Inc. director Mateus-Tique executed two transactions totaling $1,499,880 in share sales on June 22 and June 23, 2026. The sales occurred as the stock traded near its 52-week high, following a substantial 63% gain over the past year. This activity follows the company's reported strong fiscal second quarter results, which showed si…
Twist Bioscience Corp (NASDAQ:TWST) Senior Vice President of Human Resources Paula Green executed a mandatory sell-to-cover transaction on June 22, 2026, offloading 291 shares valued at $25,410. The divestment, necessitated by tax withholding requirements tied to the vesting of Restricted Stock Units, leaves Green with a direct holding of 120,414 s…
Donald A. Bergstrom, serving as President of Research and Development at Relay Therapeutics, Inc. (NASDAQ: RLAY), executed a significant divestment of company equity on June 22, 2026. The transaction involved the sale of 93,456 shares of common stock, generating a total proceeds value of $1,583,144. This sale was facilitated through the exercise of…
Eynav Azaria, serving as the Chief Product, Engineering, and Marketing Officer at Kaltura Inc., executed a sale of 10,217 shares of the company's common stock on June 18, 2026. The transaction, valued at $14,344, was conducted under a Rule 10b5-1 trading plan that Azaria established on December 15, 2025. This disposition brings her direct holding t…
